Australia's most trusted
source of pharma news
Saturday, 14 December 2024
Posted 26 November 2024 AM
Pfizer has cut jobs in Australia following a review of the "efficiency of its commercial operations" but describes the impact on headcount as small. The exact number of employees made redundant has not been disclosed.
"Our focus is on our colleagues impacted by this decision and providing them with support and appropriate services," a Pfizer spokesperson told Pharma in Focus.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.